VOGLIDIN M.3
VOGLIDIN M.3 contains Voglibose 0.3 mg + Metformin 500 mg, a dual-action combination designed to control type 2 diabetes effectively, especially after meals. Voglibose delays carbohydrate digestion to reduce post-meal sugar spikes, while Metformin lowers liver glucose production and improves insulin sensitivity. This combination helps achieve better blood sugar stability and supports long-term glycemic control in diabetic patients.
Related products
SITPIN 100
SITPIN 100 contains Sitagliptin 100 mg, a DPP-4 inhibitor used to manage blood sugar levels...
MUCINIL TAB
COMPOSITION : N acetyl cysteine 150 mg and taurine 500 mg
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of...
GLIPDIP M FORTE
GLIPDIP M FORTE is a combination therapy designed for better control of type 2 diabetes...
DUET ACT 2 FORTE
DUET ACT 2 FORTE Tablet is a combination medicine used for effective management of type...
GLIDA 2
Composition : glimepiride 40 mg
Metix-1000
Metix-1000 Tablet contains Metformin 1000 mg, a commonly prescribed medicine for managing type 2 diabetes....
